Clarithromycin Tablets IP 250 mg – ALCLAR 250
Composition – Clarithromycin I.P. 250 mg.
Description:
The composition of Clarithromycin Tablets IP 250 mg is a second-generation macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It shows high efficacy against both typical and atypical pathogens. Its excellent tissue penetration and prolonged half-life ensure sustained antibacterial activity. The oral and injectable forms allow use in a wide spectrum of outpatient and inpatient scenarios, including gastrointestinal infections when combined with PPIs and amoxicillin.
KEY BENEFITS:
• Broad-Spectrum Antibacterial Action – Effective against respiratory, skin, and soft tissue infections caused by Streptococcus, Staphylococcus, Mycoplasma, H. pylori, and atypical pathogens.
• Dual Formulations for Versatile Use – Available in suspension for pediatrics, oral tablets for outpatients, and injection for severe systemic infections — ensuring complete flexibility.
• H. pylori Eradication in GI Use – A key component in triple therapy for H. pylori eradication, improving peptic ulcer healing rates.
Targeted specalists:
• ENT Specialists
• Pulmonologists
• Dermatologists
Disclaimer:
To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion










